FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103702213> ?p ?o ?g. }

• W2103702213 endingPage "5406" @default.
• W2103702213 startingPage "5401" @default.
• W2103702213 abstract "Amrubicin, a new anthracycline agent, and topotecan are both active for previously treated small-cell lung cancer (SCLC). No comparative study of these agents has been reported. This randomized phase II study was conducted to select amrubicin or topotecan for future evaluation.Patients with SCLC previously treated with platinum-containing chemotherapy were randomly assigned to receive amrubicin (40 mg/m(2) on days 1 through 3) or topotecan (1.0 mg/m(2) on days 1 through 5). Patients were stratified by Eastern Cooperative Oncology Group performance status (0, 1, or 2) and type of relapse (chemotherapy sensitive or refractory). The primary end point was overall response rate (ORR), and secondary end points were progression-free survival (PFS), overall survival, and toxicity profile.From February 2004 to July 2007, 60 patients were enrolled, and 59 patients (36 patients with sensitive and 23 patients with refractory relapse) were assessable for efficacy and safety evaluation. Neutropenia was severe, and one treatment-related death owing to infection was observed in the amrubicin arm. ORRs were 38% (95% CI, 20% to 56%) for the amrubicin arm and 13% (95% CI, 1% to 25%) for the topotecan arm. In sensitive relapse, ORRs were 53% for the amrubicin arm and 21% for the topotecan arm. In refractory relapse, ORRs were 17% for the amrubicin arm and 0% for the topotecan arm. Median PFS was 3.5 months for patients in the amrubicin arm and 2.2 months for patients in the topotecan arm. Multivariate analysis revealed that amrubicin has more influence than topotecan on overall survival.Amrubicin may be superior to topotecan with acceptable toxicity for previously treated patients with SCLC. Further evaluation of amrubicin for relapsed SCLC is warranted." @default.
• W2103702213 created "2016-06-24" @default.
• W2103702213 creator A5000919851 @default.
• W2103702213 creator A5003433296 @default.
• W2103702213 creator A5007143858 @default.
• W2103702213 creator A5010341904 @default.
• W2103702213 creator A5013199621 @default.
• W2103702213 creator A5013639346 @default.
• W2103702213 creator A5014048360 @default.
• W2103702213 creator A5027793647 @default.
• W2103702213 creator A5037746646 @default.
• W2103702213 creator A5047702281 @default.
• W2103702213 creator A5056446724 @default.
• W2103702213 creator A5069605886 @default.
• W2103702213 creator A5071346122 @default.
• W2103702213 creator A5077670186 @default.
• W2103702213 creator A5080846994 @default.
• W2103702213 creator A5084884538 @default.
• W2103702213 date "2008-11-20" @default.
• W2103702213 modified "2023-10-17" @default.
• W2103702213 title "Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402" @default.
• W2103702213 cites W1800874491 @default.
• W2103702213 cites W1891874310 @default.
• W2103702213 cites W1919288105 @default.
• W2103702213 cites W1932169383 @default.
• W2103702213 cites W1952431753 @default.
• W2103702213 cites W1965274188 @default.
• W2103702213 cites W1981137973 @default.
• W2103702213 cites W1983509220 @default.
• W2103702213 cites W1990990694 @default.
• W2103702213 cites W2000159952 @default.
• W2103702213 cites W2033060690 @default.
• W2103702213 cites W2054935156 @default.
• W2103702213 cites W2076307253 @default.
• W2103702213 cites W2083479855 @default.
• W2103702213 cites W2083904374 @default.
• W2103702213 cites W2103786242 @default.
• W2103702213 cites W2106806844 @default.
• W2103702213 cites W2115465348 @default.
• W2103702213 cites W2131664752 @default.
• W2103702213 cites W2142055223 @default.
• W2103702213 cites W2185382808 @default.
• W2103702213 cites W2260360964 @default.
• W2103702213 cites W2590956466 @default.
• W2103702213 cites W4236014139 @default.
• W2103702213 cites W4247996612 @default.
• W2103702213 doi "https://doi.org/10.1200/jco.2008.18.1974" @default.
• W2103702213 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18854562" @default.
• W2103702213 hasPublicationYear "2008" @default.
• W2103702213 type Work @default.
• W2103702213 sameAs 2103702213 @default.
• W2103702213 citedByCount "212" @default.
• W2103702213 countsByYear W21037022132012 @default.
• W2103702213 countsByYear W21037022132013 @default.
• W2103702213 countsByYear W21037022132014 @default.
• W2103702213 countsByYear W21037022132015 @default.
• W2103702213 countsByYear W21037022132016 @default.
• W2103702213 countsByYear W21037022132017 @default.
• W2103702213 countsByYear W21037022132018 @default.
• W2103702213 countsByYear W21037022132019 @default.
• W2103702213 countsByYear W21037022132020 @default.
• W2103702213 countsByYear W21037022132021 @default.
• W2103702213 countsByYear W21037022132022 @default.
• W2103702213 countsByYear W21037022132023 @default.
• W2103702213 crossrefType "journal-article" @default.
• W2103702213 hasAuthorship W2103702213A5000919851 @default.
• W2103702213 hasAuthorship W2103702213A5003433296 @default.
• W2103702213 hasAuthorship W2103702213A5007143858 @default.
• W2103702213 hasAuthorship W2103702213A5010341904 @default.
• W2103702213 hasAuthorship W2103702213A5013199621 @default.
• W2103702213 hasAuthorship W2103702213A5013639346 @default.
• W2103702213 hasAuthorship W2103702213A5014048360 @default.
• W2103702213 hasAuthorship W2103702213A5027793647 @default.
• W2103702213 hasAuthorship W2103702213A5037746646 @default.
• W2103702213 hasAuthorship W2103702213A5047702281 @default.
• W2103702213 hasAuthorship W2103702213A5056446724 @default.
• W2103702213 hasAuthorship W2103702213A5069605886 @default.
• W2103702213 hasAuthorship W2103702213A5071346122 @default.
• W2103702213 hasAuthorship W2103702213A5077670186 @default.
• W2103702213 hasAuthorship W2103702213A5080846994 @default.
• W2103702213 hasAuthorship W2103702213A5084884538 @default.
• W2103702213 hasConcept C121332964 @default.
• W2103702213 hasConcept C121608353 @default.
• W2103702213 hasConcept C126322002 @default.
• W2103702213 hasConcept C141071460 @default.
• W2103702213 hasConcept C142424586 @default.
• W2103702213 hasConcept C143998085 @default.
• W2103702213 hasConcept C168563851 @default.
• W2103702213 hasConcept C203092338 @default.
• W2103702213 hasConcept C2776256026 @default.
• W2103702213 hasConcept C2776694085 @default.
• W2103702213 hasConcept C2776802502 @default.
• W2103702213 hasConcept C2776907518 @default.
• W2103702213 hasConcept C2777063308 @default.
• W2103702213 hasConcept C2778850193 @default.
• W2103702213 hasConcept C2781209748 @default.
• W2103702213 hasConcept C530470458 @default.
• W2103702213 hasConcept C71924100 @default.

• next